Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

NIH × Vasculitis × Etanercept × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Inflammation 3 Vasculitis 2 Uveitis 2 Granulomatosis with Polyangiitis 2 Arthritis, Juvenile 2 Temporomandibular Joint Disorders 1 Stomatitis 1 Pneumonia 1 Neoplasms 1 Metabolic Syndrome 1 Asthma 1 Arthritis, Rheumatoid 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00001901 2008-03-04

Etanercept to Treat Wegener's Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Vasculitis, Granulomatosis with Polyangiitis

NCT00005007 2007-12-28

Etanercept for Wegener's Granulomatosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase 2/3 Completed

Vasculitis, Granulomatosis with Polyangiitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡